AlphaCentric Advisors’s Axsome Therapeutics AXSM Stock Holding History

AlphaCentric Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$944K	Sell
2024 Q2	$1.21M	Sell
2024 Q1	$2.59M	Buy
2021 Q4	–	Sell
2021 Q3	$758K	Buy
2021 Q2	$810K	Buy
2021 Q1	$566K	Buy